Cover Image
市場調查報告書

戴氏-薩克斯氏病 (TSD) :主要9個市場預測 2016-2026年

Tay Sachs Disease (TSD) in 9 Major Markets 2016-2026

出版商 Black Swan Analysis 商品編碼 355844
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
戴氏-薩克斯氏病 (TSD) :主要9個市場預測 2016-2026年 Tay Sachs Disease (TSD) in 9 Major Markets 2016-2026
出版日期: 2016年04月06日 內容資訊: 英文 36 Pages
簡介

本報告提供主要9個市場 (美國、法國、德國、義大利、西班牙、英國、巴西、日本及印度) 的戴氏-薩克斯氏病的目前患者數 (性別、各年齡世代) 調查分析,目前盛行率,加上疾病概要,危險因素,疾病診斷與預後,主要的症狀和併發症等系統性資訊。

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:各地區/民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化患者數的手法

TSD的最大患病人數

  • TSD患者的遺傳性特徵
  • TSD表現型的分類
  • 兒童TSD的合併症
  • 遲發性TSD的合併症

簡稱

相關出版

病患人數的線上資料庫

病患人數的產品

價格的線上資料、平台

參考文獻

附錄

目錄

image1

Hexosaminidase A deficiency (HEX A deficiency) results in a group of neurodegenerative disorders caused by the dysfunctional activity of the specific glycosphingolipid GM2 ganglioside. The disease occurs when cell membrane components known as gangliosides, accumulate to toxic levels, particularly in neurons in the brain and spinal cord, leading to the destruction of neurons and interference with biological functions. The predominant HEX A deficiency is Tay-Sachs disease (TSD) with its common acute infantile variant, which begins around six months of age and usually results in death by the age of four. Alternative variants of the pathology are the juvenile and the adult-onset TSD types.

This report provides the current prevalent population for Tay Sachs disease across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Tay-Sachs have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Tay-Sachs disease include:

  • Visual problems
  • Low muscle tone
  • Seizures
  • Neuromuscular abnormalities
  • Speech disturbances
  • Cerebellar dysfunctions/Impaired cognitive status

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Tay-Sachs disease's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Tay-Sachs disease and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Tay-Sachs disease prevalent population.
  • Identify sub-populations within Tay-Sachs disease which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Tay-Sachs disease patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, IN

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions /Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for TSD

  • Genetic Features of TSD Patients
  • TSD Phenotype Classification
  • Co-morbidities within Infantile TSD
  • Co-morbidities within Late-Onset TSD

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • Prevalence of Tay-Sachs Disease, total (000s)
  • Prevalence of Tay-Sachs Disease, males (000s)
  • Prevalence of Tay-Sachs Disease, females (000s)
  • Prevalence of class of variant alleles of Tay-Sachs patients, total (000s)
  • Prevalence of Tay-Sachs patients by phenotype, total (000s)
  • Low muscle tone in infantile Tay-Sachs patients, total (000s)
  • Seizures in infantile Tay-Sachs patients, total (000s)
  • Visual problems in infantile Tay-Sachs patients, total (000s)
  • Neuromuscular abnormalities in Late-onset Tay-Sachs Disease, total (000s)
  • Speech disturbances in Late-onset Tay-Sachs Disease, total (000s)
  • Impaired Cognitive status in Late-onset Tay-Sachs Disease, total (000s)
  • Abbreviations and acronyms used in the report
  • USA Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • USA Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
  • France Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • France Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
  • Germany Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • Germany Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
  • Italy Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • Italy Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
  • Spain Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • Spain Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
  • Japan Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • Japan Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
  • India Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
  • India Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
Back to Top